13.990USD+13.990æéå€ååŒÂ 03/27, 20:00 (ET)
11.46BæäŸ¡ç·é¡
17.63çŽè¿12ã¶æPER
Dr Reddy's Laboratories Ltd
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKeyã®Dr Reddy's Laboratories Ltdã®æ ªåŒã¹ã³ã¢
é貚: USD æŽæ°æå»: 2026-03-26 äž»èŠã€ã³ãµã€ã
Dr Reddy's Laboratories Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å
šã§ããæ¥çããªãŒãããESGé瀺ãšãšãã«ãæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯157äž48äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯14.59ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Dr Reddy's Laboratories Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Dr Reddy's Laboratories Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
財åå¥å
šæ§
é貚: USD æŽæ°æå»: 2026-03-26 Dr Reddy's Laboratories Ltdã®çŸåšã®è²¡åã¹ã³ã¢ã¯8.46ã§ãå»è¬åæ¥çã«ãããã©ã³ãã³ã°ã¯157瀟äž59äœã§ãã ãã®è²¡åç¶æ³ã¯å®å®ã§ãã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®å£²äžé«ã¯979.80Mã§ãåå¹Žåææ¯æžå°ã®1.02%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯æžå°ã®18.84%ãšãªããŸããã
é¢é£èšäº
çŸéããã³çŸéåçç©
ç·è³ç£
è² åµåèš
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ç·å£²äžé«
å¶æ¥å©ç
ç·è³ç£
販売費 & äžè¬ç®¡çè²»

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
çšåŒåŸå©ç

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Dr Reddy's Laboratories Ltdã®äŒæ¥äŸ¡å€è©äŸ¡
é貚: USD æŽæ°æå»: 2026-03-26Dr Reddy's Laboratories Ltdã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯6.86ã§ãå»è¬åæ¥çã§ã¯157瀟äž108äœã§ãã çŸåšã®PERã¯17.63ã§ãçŽè¿é«å€20.96ã18.88%äžåããçŽè¿å®å€15.39ã12.70%äžåã£ãŠããŸãã
ããªã¥ãšãŒã·ã§ã³
PER
PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
PSR
PCFR
æ¥çå
é äœ 48/157

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-03-26Dr Reddy's Laboratories Ltdã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.00ã§ãå»è¬åæ¥çã§ã¯157瀟äž57äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯14.53ã§ãæé«ã¯18.82ãæäœã¯11.90ã§ãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Dr Reddy's Laboratories Ltd
RDY
3
Vertex Pharmaceuticals Inc
VRTX
33
財åäºæž¬

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
æ ªäŸ¡ã¢ã¡ã³ã¿ã
é貚: USD æŽæ°æå»: 2026-03-26Dr Reddy's Laboratories Ltdã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯7.07ã§ãå»è¬åæ¥çã§ã¯157瀟äž52äœã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·14.45ãšæ¯æç·13.24ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ææš
î°
î°
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ
ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ
å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
ææš
売ã(3)
äžç«(2)
è²·ã(2)
ç§»åå¹³å
売ã(5)
äžç«(0)
è²·ã(1)
æ©é¢æè³å®¶ã®ä¿¡é Œæ
é貚: USD æŽæ°æå»: 2026-03-26Dr Reddy's Laboratories Ltdã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯3.00ã§ãå»è¬åæ¥çã§ã¯157瀟äž93äœã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯13.84%ã§ãåååææ¯å¢å 2.39%ã§ãã æå€§ã®æ©é¢æè³å®¶ã¯ãžã§ãŒã ãºã»ã·ã¢ã³ãºã§ãåèš8.26Mæ ªïŒçºè¡æžæ ªåŒã®0.99%ïŒãä¿æããŠãããä¿ææ¯çã¯æžå°10.28%ã§ãã
æ©é¢æè³å®¶ä¿ææ ª

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»åå
Robeco Institutional Asset Management B.V.
RBC Global Asset Management (UK) Limited
Aikya Investment Management Limited
Dimensional Fund Advisors, L.P.
Parametric Portfolio Associates LLC
BNP Paribas Securities Corp. North America
State Street Investment Management (US)
ãªã¹ã¯è©äŸ¡î°î°
é貚: USD æŽæ°æå»: 2026-03-26ç±³ãã«ææ°ã¯çŸåšäžç«ã®ç¶æ
ã«ãããå»è¬åã®å
é忥çã«äžç«çãªã®åœ±é¿ãåãŒããŠããŸãããã«ææ°ïŒDXYïŒã¯ããŠãŒããåãè±ãã³ããã«ãããã«ãã¹ãŠã§ãŒãã³ã»ã¯ããŒããã¹ã€ã¹ã»ãã©ã³ãå«ãäž»èŠé貚ãã¹ã±ããã«å¯Ÿããç±³ãã«ã®äŸ¡å€ã枬å®ãããã®ã§ãã Dr Reddy's Laboratories Ltdã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯9.40ã§ãå»è¬åæ¥çã§ã¯157瀟äž9äœã§ãã å瀟ã®ããŒã¿å€ã¯0.35ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯äžèœå¹
ãéå®çãšãªãåŸåã瀺ããŠããŸãã æ¥çããªãŒãããESGé瀺ãšãšãã«ã
S&P 500ææ°ãšã®ããŒã¿å€
0.35
240æ¥éã®æå€§ãããŒããŠã³
+20.10%
240æ¥éã®ãã©ãã£ãªãã£
+21.96%
æ»ã
æ¥æ¬¡ãªã¿ãŒã³ïŒæå€§ïŒ
æ¥æ¬¡ãªã¿ãŒã³ïŒæå°ïŒ
ãªã¹ã¯è©äŸ¡
ãªã¿ãŒã³/ãããŒããŠã³æ¯ç
ãã©ãã£ãªãã£
å®çŸãã©ãã£ãªãã£
æšæºåãã¥ã«ãŒã¬ã³ãž
ããŠã³ãµã€ããªã¹ã¯èª¿æŽåŸãªã¿ãŒã³
æå€§æ¥æ¬¡äžæãã©ãã£ãªãã£
æå€§æ¥æ¬¡äžèœãã©ãã£ãªãã£
æµåæ§
売買å転çã®å€åå¹

Dr Reddy's Laboratories Ltd
RDY
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

United Therapeutics Corp
UTHR
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Jazz Pharmaceuticals PLC
JAZZ
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Ligand Pharmaceuticals Inc
LGND
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Kiniksa Pharmaceuticals International PLC
KNSA
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
詳现ãèŠã